The Scientist

» peer review and developmental biology

Most Recent

image: Viral Protector

Viral Protector

By | April 21, 2015

A retrovirus embedded in the human genome may help protect embryos from other viruses, and influence fetal development.

1 Comment

image: WHO: Share Trial Data

WHO: Share Trial Data

By | April 15, 2015

The World Health Organization again calls upon researchers to register clinical trial details in freely accessible databases before initiation of the study.

0 Comments

image: Contributors

Contributors

By | April 1, 2015

Meet some of the people featured in the April 2015 issue of The Scientist.

0 Comments

image: From Many, One

From Many, One

By | April 1, 2015

Diverse mammals, including humans, have been found to carry distinct genomes in their cells. What does such genetic chimerism mean for health and disease?

4 Comments

image: Fast-Track Peer Review Controversy

Fast-Track Peer Review Controversy

By | March 31, 2015

An editor of the journal Scientific Reports quits in protest of paid, expedited review.

4 Comments

image: Mass Retraction

Mass Retraction

By | March 27, 2015

BioMed Central retracts 43 papers it had been investigating for evidence of faked peer review.

1 Comment

image: Short, Strong Signals

Short, Strong Signals

By | March 25, 2015

Methylation increases both the activity and instability of the signaling protein Notch.

0 Comments

image: Judge: PubPeer Users Remain Anonymous

Judge: PubPeer Users Remain Anonymous

By | March 6, 2015

A Michigan judge denies a request to reveal the identities of commenters on the post-publication review website.

2 Comments

image: <em>Nature</em> Debuts Peer-Review Option

Nature Debuts Peer-Review Option

By | February 18, 2015

Authors submitting to Nature journals can soon request double-blind reviews.

1 Comment

image: Scientific Publishing, 1665

Scientific Publishing, 1665

By | February 1, 2015

Henry Oldenburg founded Philosophical Transactions to share scholarly news from the “Ingenious in many considerable parts of the World.”

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS